NIBSC標準品
| 參考價 | ￥ 100 |
| 訂貨量 | ≥1 |
具體成交價以合同協(xié)議為準
- 公司名稱 深圳遠揚醫(yī)藥科技有限公司
- 品牌
- 型號
- 產(chǎn)地
- 廠商性質(zhì) 生產(chǎn)廠家
- 更新時間 2016/4/13 14:47:14
- 訪問次數(shù) 522
產(chǎn)品標簽
聯(lián)系我們時請說明是化工儀器網(wǎng)上看到的信息，謝謝!
NIBSC標準品 產(chǎn)品介紹：
美國劍橋同位素CIL是世界上*個生產(chǎn)穩(wěn)定性同位素標記化合物的生產(chǎn)商，以其的技術(shù)雄踞同位素分離領(lǐng)域。20年來，CIL一直研究穩(wěn)定性同位素與穩(wěn)定性同位素標記化合物的開發(fā)，生產(chǎn)。主要標記性同位素有13C、12C、D、15N、18O和17O，目前已經(jīng)擁有8000多種標記化合物。CIL的產(chǎn)品均能應(yīng)用于不同的領(lǐng)域，如物理，化學，生物醫(yī)學，分析，診斷研究以及環(huán)境測試。
NIBSC標準品
深圳遠揚醫(yī)藥科技有限公司
Contact:何
M.O.B：150 1245 6311
Q.Q：78100 7885
部分產(chǎn)品列表：
| 01/434 | Meningococcal serogroup W polysaccharide |
| 10/177 | Reteplase Reference Material |
| 13/283 | Polio Anti Sabin type 66 (inactivated) Serum |
| 10/141 | Reteplase Reference Material |
| 13/195 | Influenza Antigen B/Massachusetts/02/2073 (Egg derived) |
| 10/124 | Reteplase Reference Material |
| 95/600 | Interleukin-61 (Human, rDNA derived) |
| 03/104-031 | HTLV-16 (antibody) Monitor Sample |
| 01/431 | Meningococcal serogroup W polysaccharide |
| 10/209 | Reteplase Reference Material |
| 07/294 | BCG Vaccine of Russian BCG-I sub-strain(21st WHO Reference Reagent) |
| 12/B623-080 | QCRFLUAH1N1QC1-Influenza AH1N1 QC78 |
| 13/199 | C-Peptide, Human. 54st International Standard. |
| 13/197 | C-Peptide, Human. 52st International Standard. |
| 03/104-027 | HTLV-12 (antibody) Monitor Sample |
| 10/110 | Reteplase Reference Material |
| 13/198 | C-Peptide, Human. 53st International Standard. |
| 13/174 | Influenza Antigen B/Massachusetts/02/2052 (Egg derived) |
| 07/334 | BCG Vaccine of Russian BCG-I sub-strain(61st WHO Reference Reagent) |
| 12/B623-004 | QCRFLUAH1N1QC1-Influenza AH1N1 QC2 |
| 01/457 | Meningococcal serogroup W polysaccharide |
| 95/620 | Interleukin-81 (Human, rDNA derived) |
| 07/289 | BCG Vaccine of Russian BCG-I sub-strain(16st WHO Reference Reagent) |
| 01/534 | Meningococcal serogroup W polysaccharide |
| 10/205 | Reteplase Reference Material |
| 07/360 | BCG Vaccine of Russian BCG-I sub-strain(87st WHO Reference Reagent) |
| 03/104-071 | HTLV-56 (antibody) Monitor Sample |
| 12/B623-029 | QCRFLUAH1N1QC1-Influenza AH1N1 QC27 |
| 10/164 | Reteplase Reference Material |
| 13/205 | Influenza Antigen B/Massachusetts/02/2083 (Egg derived) |
| 13/218 | Polio Anti Sabin type 1 (inactivated) Serum |
| 03/104-066 | HTLV-51 (antibody) Monitor Sample |
| 13/190 | C-Peptide, Human. 45st International Standard. |
| 10/113 | Reteplase Reference Material |
| 13/233 | Influenza Antigen B/Massachusetts/02/2111 (Egg derived) |
| 07/297 | BCG Vaccine of Russian BCG-I sub-strain(24st WHO Reference Reagent) |
| 10/178 | Reteplase Reference Material |
| 03/104-064 | HTLV-49 (antibody) Monitor Sample |
| 07/285 | BCG Vaccine of Russian BCG-I sub-strain(12st WHO Reference Reagent) |
| 13/316 | Polio Anti Sabin type 99 (inactivated) Serum |
| 13/139 | Influenza Antigen B/Massachusetts/02/2017 (Egg derived) |
| 01/475 | Meningococcal serogroup W polysaccharide |
| 13/324 | Polio Anti Sabin type 107 (inactivated) Serum |
| 13/138 | Influenza Antigen B/Massachusetts/02/2016 (Egg derived) |
| 01/508 | Meningococcal serogroup W polysaccharide |
| 03/104-036 | HTLV-21 (antibody) Monitor Sample |
| 13/229 | C-Peptide, Human. 84st International Standard. |
| 03/104-103 | HTLV-88 (antibody) Monitor Sample |
| 12/B623-109 | QCRFLUAH1N1QC1-Influenza AH1N1 QC107 |
| 01/507 | Meningococcal serogroup W polysaccharide |
| 03/104-111 | HTLV-96 (antibody) Monitor Sample |
| 01/484 | Meningococcal serogroup W polysaccharide |
| 95/561 | Interleukin-22 (Human, rDNA derived) |
| 95/574 | Interleukin-35 (Human, rDNA derived) |
| 07/298 | BCG Vaccine of Russian BCG-I sub-strain(25st WHO Reference Reagent) |
| 13/184 | C-Peptide, Human. 39st International Standard. |
| 95/599 | Interleukin-60 (Human, rDNA derived) |
| 13/238 | C-Peptide, Human. 93st International Standard. |
| 13/156 | C-Peptide, Human. 11st International Standard. |
| 12/B623-110 | QCRFLUAH1N1QC1-Influenza AH1N1 QC108 |
| 10/191 | Reteplase Reference Material |
| 13/170 | C-Peptide, Human. 25st International Standard. |
| 03/104-116 | HTLV-101 (antibody) Monitor Sample |
| 10/137 | Reteplase Reference Material |
| 07/345 | BCG Vaccine of Russian BCG-I sub-strain(72st WHO Reference Reagent) |
| 12/B623-062 | QCRFLUAH1N1QC1-Influenza AH1N1 QC60 |
| 95/591 | Interleukin-52 (Human, rDNA derived) |
| 03/104-078 | HTLV-63 (antibody) Monitor Sample |
| 13/177 | Influenza Antigen B/Massachusetts/02/2055 (Egg derived) |
| 10/202 | Reteplase Reference Material |
| 13/250 | Polio Anti Sabin type 33 (inactivated) Serum |
| 10/109 | Reteplase Reference Material |
| 95/601 | Interleukin-62 (Human, rDNA derived) |
| 13/231 | Polio Anti Sabin type 14 (inactivated) Serum |
| 13/167 | C-Peptide, Human. 22st International Standard. |
| 07/332 | BCG Vaccine of Russian BCG-I sub-strain(59st WHO Reference Reagent) |
| 12/B623-007 | QCRFLUAH1N1QC1-Influenza AH1N1 QC5 |
| 03/104-059 | HTLV-44 (antibody) Monitor Sample |
| 13/238 | Influenza Antigen B/Massachusetts/02/2116 (Egg derived) |
| 95/645 | Interleukin-106 (Human, rDNA derived) |
| 13/203 | C-Peptide, Human. 58st International Standard. |
| 01/519 | Meningococcal serogroup W polysaccharide |
| 12/B623-067 | QCRFLUAH1N1QC1-Influenza AH1N1 QC65 |
| 13/294 | Polio Anti Sabin type 77 (inactivated) Serum |
| 13/154 | Influenza Antigen B/Massachusetts/02/2032 (Egg derived) |
| 95/568 | Interleukin-29 (Human, rDNA derived) |
| 13/181 | C-Peptide, Human. 36st International Standard. |
| 13/158 | C-Peptide, Human. 13st International Standard. |
| 13/194 | Influenza Antigen B/Massachusetts/02/2072 (Egg derived) |
| 13/309 | Polio Anti Sabin type 92 (inactivated) Serum |
| 07/327 | BCG Vaccine of Russian BCG-I sub-strain(54st WHO Reference Reagent) |
| 07/353 | BCG Vaccine of Russian BCG-I sub-strain(80st WHO Reference Reagent) |
| 03/104-061 | HTLV-46 (antibody) Monitor Sample |
| 03/104-112 | HTLV-97 (antibody) Monitor Sample |
| 13/233 | C-Peptide, Human. 88st International Standard. |
| 12/B623-066 | QCRFLUAH1N1QC1-Influenza AH1N1 QC64 |
| 95/648 | Interleukin-109 (Human, rDNA derived) |
| 01/464 | Meningococcal serogroup W polysaccharide |
| 03/104-094 | HTLV-79 (antibody) Monitor Sample |
| 07/370 | BCG Vaccine of Russian BCG-I sub-strain(97st WHO Reference Reagent) |
| 13/246 | C-Peptide, Human. 101st International Standard. |
| 07/320 | BCG Vaccine of Russian BCG-I sub-strain(47st WHO Reference Reagent) |
| 12/B623-103 | QCRFLUAH1N1QC1-Influenza AH1N1 QC101 |
| 13/299 | Polio Anti Sabin type 82 (inactivated) Serum |
| 13/231 | Influenza Antigen B/Massachusetts/02/2109 (Egg derived) |
| 13/185 | Influenza Antigen B/Massachusetts/02/2063 (Egg derived) |
| 07/307 | BCG Vaccine of Russian BCG-I sub-strain(34st WHO Reference Reagent) |
| 12/B623-044 | QCRFLUAH1N1QC1-Influenza AH1N1 QC42 |
| 12/B623-024 | QCRFLUAH1N1QC1-Influenza AH1N1 QC22 |
| 95/646 | Interleukin-107 (Human, rDNA derived) |
| 13/241 | C-Peptide, Human. 96st International Standard. |
| 10/107 | Reteplase Reference Material |
| 13/254 | Polio Anti Sabin type 37 (inactivated) Serum |
| 13/171 | Influenza Antigen B/Massachusetts/02/2049 (Egg derived) |
| 01/449 | Meningococcal serogroup W polysaccharide |
| 13/168 | C-Peptide, Human. 23st International Standard. |
| 13/216 | Influenza Antigen B/Massachusetts/02/2094 (Egg derived) |
| 03/104-108 | HTLV-93 (antibody) Monitor Sample |
| 13/236 | Polio Anti Sabin type 19 (inactivated) Serum |
| 07/355 | BCG Vaccine of Russian BCG-I sub-strain(82st WHO Reference Reagent) |
| 13/179 | Influenza Antigen B/Massachusetts/02/2057 (Egg derived) |
| 07/308 | BCG Vaccine of Russian BCG-I sub-strain(35st WHO Reference Reagent) |
| 01/474 | Meningococcal serogroup W polysaccharide |
| 12/B623-008 | QCRFLUAH1N1QC1-Influenza AH1N1 QC6 |
| 12/B623-083 | QCRFLUAH1N1QC1-Influenza AH1N1 QC81 |
| 13/182 | Influenza Antigen B/Massachusetts/02/2060 (Egg derived) |
| 13/258 | Polio Anti Sabin type 41 (inactivated) Serum |
| 13/155 | Influenza Antigen B/Massachusetts/02/2033 (Egg derived) |
| 10/185 | Reteplase Reference Material |
| 12/B623-054 | QCRFLUAH1N1QC1-Influenza AH1N1 QC52 |
| 10/126 | Reteplase Reference Material |
| 13/213 | Influenza Antigen B/Massachusetts/02/2091 (Egg derived) |
| 10/204 | Reteplase Reference Material |
| 03/104-058 | HTLV-43 (antibody) Monitor Sample |
| 10/114 | Reteplase Reference Material |
| 01/432 | Meningococcal serogroup W polysaccharide |
| 12/B623-026 | QCRFLUAH1N1QC1-Influenza AH1N1 QC24 |
| 95/569 | Interleukin-30 (Human, rDNA derived) |
| 03/104-073 | HTLV-58 (antibody) Monitor Sample |
| 95/592 | Interleukin-53 (Human, rDNA derived) |
| 95/635 | Interleukin-96 (Human, rDNA derived) |
| 95/652 | Interleukin-113 (Human, rDNA derived) |
| 03/104-045 | HTLV-30 (antibody) Monitor Sample |
| 12/B623-104 | QCRFLUAH1N1QC1-Influenza AH1N1 QC102 |
| 13/230 | C-Peptide, Human. 85st International Standard. |
| 13/259 | Polio Anti Sabin type 42 (inactivated) Serum |
| 12/B623-061 | QCRFLUAH1N1QC1-Influenza AH1N1 QC59 |
| 13/239 | Polio Anti Sabin type 22 (inactivated) Serum |
| 13/186 | Influenza Antigen B/Massachusetts/02/2064 (Egg derived) |
| 07/314 | BCG Vaccine of Russian BCG-I sub-strain(41st WHO Reference Reagent) |
| 10/105 | Reteplase Reference Material |
| 07/329 | BCG Vaccine of Russian BCG-I sub-strain(56st WHO Reference Reagent) |
| 13/152 | Influenza Antigen B/Massachusetts/02/2030 (Egg derived) |
| 12/B623-006 | QCRFLUAH1N1QC1-Influenza AH1N1 QC4 |
| 13/314 | Polio Anti Sabin type 97 (inactivated) Serum |
| 95/590 | Interleukin-51 (Human, rDNA derived) |
| 13/143 | Influenza Antigen B/Massachusetts/02/2021 (Egg derived) |
| 07/293 | BCG Vaccine of Russian BCG-I sub-strain(20st WHO Reference Reagent) |
| 07/287 | BCG Vaccine of Russian BCG-I sub-strain(14st WHO Reference Reagent) |
| 95/576 | Interleukin-37 (Human, rDNA derived) |
| 01/481 | Meningococcal serogroup W polysaccharide |
| 13/135 | Influenza Antigen B/Massachusetts/02/2013 (Egg derived) |
| 95/641 | Interleukin-102 (Human, rDNA derived) |
| 07/284 | BCG Vaccine of Russian BCG-I sub-strain(11st WHO Reference Reagent) |
| 13/187 | C-Peptide, Human. 42st International Standard. |
| 13/180 | Influenza Antigen B/Massachusetts/02/2058 (Egg derived) |
| 13/232 | Polio Anti Sabin type 15 (inactivated) Serum |
| 01/518 | Meningococcal serogroup W polysaccharide |
| 13/228 | C-Peptide, Human. 83st International Standard. |
| 07/290 | BCG Vaccine of Russian BCG-I sub-strain(17st WHO Reference Reagent) |
| 10/199 | Reteplase Reference Material |
| 13/227 | Influenza Antigen B/Massachusetts/02/2105 (Egg derived) |
| 10/117 | Reteplase Reference Material |
| 12/B623-058 | QCRFLUAH1N1QC1-Influenza AH1N1 QC56 |
| 03/104-068 | HTLV-53 (antibody) Monitor Sample |
| 07/375 | BCG Vaccine of Russian BCG-I sub-strain(102st WHO Reference Reagent) |
| 01/452 | Meningococcal serogroup W polysaccharide |
| 13/234 | C-Peptide, Human. 89st International Standard. |
| 13/286 | Polio Anti Sabin type 69 (inactivated) Serum |
| 13/189 | C-Peptide, Human. 44st International Standard. |
| 03/104-043 | HTLV-28 (antibody) Monitor Sample |
| 95/586 | Interleukin-47 (Human, rDNA derived) |
| 95/615 | Interleukin-76 (Human, rDNA derived) |
| 12/B623-056 | QCRFLUAH1N1QC1-Influenza AH1N1 QC54 |
| 13/206 | C-Peptide, Human. 61st International Standard. |
| 01/517 | Meningococcal serogroup W polysaccharide |
| 07/368 | BCG Vaccine of Russian BCG-I sub-strain(95st WHO Reference Reagent) |
| 03/104-095 | HTLV-80 (antibody) Monitor Sample |
| 07/344 | BCG Vaccine of Russian BCG-I sub-strain(71st WHO Reference Reagent) |
| 10/160 | Reteplase Reference Material |
| 13/243 | C-Peptide, Human. 98st International Standard. |
| 12/B623-074 | QCRFLUAH1N1QC1-Influenza AH1N1 QC72 |
| 03/104-074 | HTLV-59 (antibody) Monitor Sample |
| 03/104-090 | HTLV-75 (antibody) Monitor Sample |
| 13/210 | Influenza Antigen B/Massachusetts/02/2088 (Egg derived) |
| 07/354 | BCG Vaccine of Russian BCG-I sub-strain(81st WHO Reference Reagent) |
| 13/169 | Influenza Antigen B/Massachusetts/02/2047 (Egg derived) |
| 13/215 | Influenza Antigen B/Massachusetts/02/2093 (Egg derived) |
| 07/304 | BCG Vaccine of Russian BCG-I sub-strain(31st WHO Reference Reagent) |
| 03/104-023 | HTLV-8 (antibody) Monitor Sample |
| 12/B623-022 | QCRFLUAH1N1QC1-Influenza AH1N1 QC20 |
| 03/104-109 | HTLV-94 (antibody) Monitor Sample |
| 12/B623-003 | QCRFLUAH1N1QC1-Influenza AH1N1 QC1 |
| 13/204 | Influenza Antigen B/Massachusetts/02/2082 (Egg derived) |
| 13/215 | C-Peptide, Human. 70st International Standard. |
| 95/577 | Interleukin-38 (Human, rDNA derived) |
| 13/162 | Influenza Antigen B/Massachusetts/02/2040 (Egg derived) |
| 01/488 | Meningococcal serogroup W polysaccharide |
| 01/429 | Meningococcal serogroup W polysaccharide |
| 01/493 | Meningococcal serogroup W polysaccharide |
| 01/495 | Meningococcal serogroup W polysaccharide |
| 13/176 | C-Peptide, Human. 31st International Standard. |
| 03/104-072 | HTLV-57 (antibody) Monitor Sample |
| 01/463 | Meningococcal serogroup W polysaccharide |
| 03/104-035 | HTLV-20 (antibody) Monitor Sample |
| 10/143 | Reteplase Reference Material |
| 13/158 | Influenza Antigen B/Massachusetts/02/2036 (Egg derived) |
| 13/226 | Polio Anti Sabin type 9 (inactivated) Serum |
| 10/154 | Reteplase Reference Material |
| 95/624 | Interleukin-85 (Human, rDNA derived) |
| 13/221 | Influenza Antigen B/Massachusetts/02/2099 (Egg derived) |
| 07/347 | BCG Vaccine of Russian BCG-I sub-strain(74st WHO Reference Reagent) |
| 01/512 | Meningococcal serogroup W polysaccharide |
| 13/247 | C-Peptide, Human. 102st International Standard. |
| 13/180 | C-Peptide, Human. 35st International Standard. |
| 10/153 | Reteplase Reference Material |
| 07/358 | BCG Vaccine of Russian BCG-I sub-strain(85st WHO Reference Reagent) |
| 07/321 | BCG Vaccine of Russian BCG-I sub-strain(48st WHO Reference Reagent) |
| 07/286 | BCG Vaccine of Russian BCG-I sub-strain(13st WHO Reference Reagent) |
| 07/324 | BCG Vaccine of Russian BCG-I sub-strain(51st WHO Reference Reagent) |
| 13/167 | Influenza Antigen B/Massachusetts/02/2045 (Egg derived) |
| 12/B623-020 | QCRFLUAH1N1QC1-Influenza AH1N1 QC18 |
| 03/104-044 | HTLV-29 (antibody) Monitor Sample |
| 13/282 | Polio Anti Sabin type 65 (inactivated) Serum |
| 03/104-101 | HTLV-86 (antibody) Monitor Sample |
| 10/190 | Reteplase Reference Material |
| 12/B623-079 | QCRFLUAH1N1QC1-Influenza AH1N1 QC77 |
| 12/B623-016 | QCRFLUAH1N1QC1-Influenza AH1N1 QC14 |
| 12/B623-099 | QCRFLUAH1N1QC1-Influenza AH1N1 QC97 |
| 01/522 | Meningococcal serogroup W polysaccharide |
| 13/219 | Polio Anti Sabin type 2 (inactivated) Serum |
| 12/B623-107 | QCRFLUAH1N1QC1-Influenza AH1N1 QC105 |
| 03/104-077 | HTLV-62 (antibody) Monitor Sample |
| 03/104-097 | HTLV-82 (antibody) Monitor Sample |
| 13/325 | Polio Anti Sabin type 108 (inactivated) Serum |
| 13/154 | C-Peptide, Human. 9st International Standard. |
| 01/535 | Meningococcal serogroup W polysaccharide |
| 01/477 | Meningococcal serogroup W polysaccharide |
| 95/640 | Interleukin-101 (Human, rDNA derived) |
| 10/140 | Reteplase Reference Material |
| 13/196 | C-Peptide, Human. 51st International Standard. |
| 12/B623-030 | QCRFLUAH1N1QC1-Influenza AH1N1 QC28 |
| 01/510 | Meningococcal serogroup W polysaccharide |
| 13/320 | Polio Anti Sabin type 103 (inactivated) Serum |
| 01/525 | Meningococcal serogroup W polysaccharide |
| 03/104-026 | HTLV-11 (antibody) Monitor Sample |
| 03/104-041 | HTLV-26 (antibody) Monitor Sample |
| 13/228 | Influenza Antigen B/Massachusetts/02/2106 (Egg derived) |
| 13/276 | Polio Anti Sabin type 59 (inactivated) Serum |
| 13/170 | Influenza Antigen B/Massachusetts/02/2048 (Egg derived) |
| 95/616 | Interleukin-77 (Human, rDNA derived) |
| 03/104-062 | HTLV-47 (antibody) Monitor Sample |
| 12/B623-027 | QCRFLUAH1N1QC1-Influenza AH1N1 QC25 |
| 95/651 | Interleukin-112 (Human, rDNA derived) |
| 95/628 | Interleukin-89 (Human, rDNA derived) |
| 07/295 | BCG Vaccine of Russian BCG-I sub-strain(22st WHO Reference Reagent) |
| 13/149 | Influenza Antigen B/Massachusetts/02/2027 (Egg derived) |
| 10/151 | Reteplase Reference Material |
| 07/352 | BCG Vaccine of Russian BCG-I sub-strain(79st WHO Reference Reagent) |
| 07/361 | BCG Vaccine of Russian BCG-I sub-strain(88st WHO Reference Reagent) |
| 95/556 | Interleukin-17 (Human, rDNA derived) |
| 13/295 | Polio Anti Sabin type 78 (inactivated) Serum |
| 13/220 | C-Peptide, Human. 75st International Standard. |
| 13/172 | Influenza Antigen B/Massachusetts/02/2050 (Egg derived) |
| 10/197 | Reteplase Reference Material |
| 95/660 | Interleukin-121 (Human, rDNA derived) |
| 03/104-076 | HTLV-61 (antibody) Monitor Sample |
| 01/529 | Meningococcal serogroup W polysaccharide |
| 13/256 | Polio Anti Sabin type 39 (inactivated) Serum |
| 13/317 | Polio Anti Sabin type 100 (inactivated) Serum |
| 03/104-121 | HTLV-106 (antibody) Monitor Sample |
| 12/B623-064 | QCRFLUAH1N1QC1-Influenza AH1N1 QC62 |
| 03/104-052 | HTLV-37 (antibody) Monitor Sample |
| 12/B623-106 | QCRFLUAH1N1QC1-Influenza AH1N1 QC104 |
| 13/220 | Influenza Antigen B/Massachusetts/02/2098 (Egg derived) |
| 01/527 | Meningococcal serogroup W polysaccharide |
| 13/208 | Influenza Antigen B/Massachusetts/02/2086 (Egg derived) |
| 03/104-093 | HTLV-78 (antibody) Monitor Sample |
| 13/195 | C-Peptide, Human. 50st International Standard. |
| 12/B623-052 | QCRFLUAH1N1QC1-Influenza AH1N1 QC50 |
| 13/196 | Influenza Antigen B/Massachusetts/02/2074 (Egg derived) |
| 13/226 | C-Peptide, Human. 81st International Standard. |
| 13/200 | Influenza Antigen B/Massachusetts/02/2078 (Egg derived) |
| 13/293 | Polio Anti Sabin type 76 (inactivated) Serum |
| 13/184 | Influenza Antigen B/Massachusetts/02/2062 (Egg derived) |
| 01/430 | Meningococcal serogroup W polysaccharide |
| 03/104-054 | HTLV-39 (antibody) Monitor Sample |
| 13/219 | C-Peptide, Human. 74st International Standard. |
| 10/189 | Reteplase Reference Material |
| 07/372 | BCG Vaccine of Russian BCG-I sub-strain(99st WHO Reference Reagent) |
| 10/203 | Reteplase Reference Material |
| 95/627 | Interleukin-88 (Human, rDNA derived) |
| 10/198 | Reteplase Reference Material |
| 13/162 | C-Peptide, Human. 17st International Standard. |
| 03/104-089 | HTLV-74 (antibody) Monitor Sample |
| 13/183 | C-Peptide, Human. 38st International Standard. |
| 07/333 | BCG Vaccine of Russian BCG-I sub-strain(60st WHO Reference Reagent) |
| 95/571 | Interleukin-32 (Human, rDNA derived) |
| 95/584 | Interleukin-45 (Human, rDNA derived) |
| 12/B623-088 | QCRFLUAH1N1QC1-Influenza AH1N1 QC86 |
| 13/156 | Influenza Antigen B/Massachusetts/02/2034 (Egg derived) |
| 12/B623-049 | QCRFLUAH1N1QC1-Influenza AH1N1 QC47 |
| 95/634 | Interleukin-95 (Human, rDNA derived) |
| 10/127 | Reteplase Reference Material |
| 07/274 | BCG Vaccine of Russian BCG-I sub-strain(1st WHO Reference Reagent) |
| 95/654 | Interleukin-115 (Human, rDNA derived) |
| 03/104-032 | HTLV-17 (antibody) Monitor Sample |
| 13/150 | Influenza Antigen B/Massachusetts/02/2028 (Egg derived) |
| 13/244 | Polio Anti Sabin type 27 (inactivated) Serum |
| 13/221 | C-Peptide, Human. 76st International Standard. |
| 03/104-065 | HTLV-50 (antibody) Monitor Sample |
| 03/104-115 | HTLV-100 (antibody) Monitor Sample |
| 03/104-114 | HTLV-99 (antibody) Monitor Sample |
| 13/230 | Influenza Antigen B/Massachusetts/02/2108 (Egg derived) |
| 01/471 | Meningococcal serogroup W polysaccharide |
| 13/188 | Influenza Antigen B/Massachusetts/02/2066 (Egg derived) |
| 01/486 | Meningococcal serogroup W polysaccharide |
| 07/310 | BCG Vaccine of Russian BCG-I sub-strain(37st WHO Reference Reagent) |
| 07/282 | BCG Vaccine of Russian BCG-I sub-strain(9st WHO Reference Reagent) |
| 95/562 | Interleukin-23 (Human, rDNA derived) |
| 07/331 | BCG Vaccine of Russian BCG-I sub-strain(58st WHO Reference Reagent) |
| 13/250 | C-Peptide, Human. 105st International Standard. |
| 13/279 | Polio Anti Sabin type 62 (inactivated) Serum |
| 01/454 | Meningococcal serogroup W polysaccharide |
| 95/633 | Interleukin-94 (Human, rDNA derived) |
| 13/232 | C-Peptide, Human. 87st International Standard. |
| 95/573 | Interleukin-34 (Human, rDNA derived) |
| 13/249 | Polio Anti Sabin type 32 (inactivated) Serum |
| 13/285 | Polio Anti Sabin type 68 (inactivated) Serum |
| 12/B623-086 | QCRFLUAH1N1QC1-Influenza AH1N1 QC84 |
| 01/494 | Meningococcal serogroup W polysaccharide |
| 12/B623-078 | QCRFLUAH1N1QC1-Influenza AH1N1 QC76 |
| 95/570 | Interleukin-31 (Human, rDNA derived) |
| 12/B623-039 | QCRFLUAH1N1QC1-Influenza AH1N1 QC37 |
| 13/176 | Influenza Antigen B/Massachusetts/02/2054 (Egg derived) |
| 03/104-056 | HTLV-41 (antibody) Monitor Sample |
| 13/188 | C-Peptide, Human. 43st International Standard. |
| 10/106 | Reteplase Reference Material |
| 07/339 | BCG Vaccine of Russian BCG-I sub-strain(66st WHO Reference Reagent) |
| 95/602 | Interleukin-63 (Human, rDNA derived) |
| 95/644 | Interleukin-105 (Human, rDNA derived) |
| 13/262 | Polio Anti Sabin type 45 (inactivated) Serum |
| 13/230 | Polio Anti Sabin type 13 (inactivated) Serum |
| 10/183 | Reteplase Reference Material |
| 01/514 | Meningococcal serogroup W polysaccharide |
| 12/B623-050 | QCRFLUAH1N1QC1-Influenza AH1N1 QC48 |
| 13/192 | C-Peptide, Human. 47st International Standard. |
| 13/242 | Polio Anti Sabin type 25 (inactivated) Serum |
| 12/B623-011 | QCRFLUAH1N1QC1-Influenza AH1N1 QC9 |
| 12/B623-018 | QCRFLUAH1N1QC1-Influenza AH1N1 QC16 |
| 10/192 | Reteplase Reference Material |
| 13/222 | Influenza Antigen B/Massachusetts/02/2100 (Egg derived) |
| 03/104-069 | HTLV-54 (antibody) Monitor Sample |
| 10/131 | Reteplase Reference Material |
| 13/222 | Polio Anti Sabin type 5 (inactivated) Serum |
| 13/203 | Influenza Antigen B/Massachusetts/02/2081 (Egg derived) |
| 95/559 | Interleukin-20 (Human, rDNA derived) |
| 13/207 | Influenza Antigen B/Massachusetts/02/2085 (Egg derived) |
| 95/619 | Interleukin-80 (Human, rDNA derived) |
| 10/163 | Reteplase Reference Material |
| 13/193 | Influenza Antigen B/Massachusetts/02/2071 (Egg derived) |
| 10/188 | Reteplase Reference Material |
| 01/435 | Meningococcal serogroup W polysaccharide |
| 10/170 | Reteplase Reference Material |
| 95/588 | Interleukin-49 (Human, rDNA derived) |
| 01/456 | Meningococcal serogroup W polysaccharide |
| 13/265 | Polio Anti Sabin type 48 (inactivated) Serum |
| 10/108 | Reteplase Reference Material |
| 12/B623-075 | QCRFLUAH1N1QC1-Influenza AH1N1 QC73 |
| 01/489 | Meningococcal serogroup W polysaccharide |
| 13/300 | Polio Anti Sabin type 83 (inactivated) Serum |
| 13/313 | Polio Anti Sabin type 96 (inactivated) Serum |
| 07/371 | BCG Vaccine of Russian BCG-I sub-strain(98st WHO Reference Reagent) |
| 95/582 | Interleukin-43 (Human, rDNA derived) |
| 03/104-017 | HTLV-2 (antibody) Monitor Sample |
| 01/451 | Meningococcal serogroup W polysaccharide |
| 13/208 | C-Peptide, Human. 63st International Standard. |
| 12/B623-090 | QCRFLUAH1N1QC1-Influenza AH1N1 QC88 |
| 13/213 | C-Peptide, Human. 68st International Standard. |
| 95/563 | Interleukin-24 (Human, rDNA derived) |
| 07/381 | BCG Vaccine of Russian BCG-I sub-strain(108st WHO Reference Reagent) |
| 01/523 | Meningococcal serogroup W polysaccharide |
| 07/288 | BCG Vaccine of Russian BCG-I sub-strain(15st WHO Reference Reagent) |
| 13/240 | C-Peptide, Human. 95st International Standard. |
| 13/223 | C-Peptide, Human. 78st International Standard. |
| 13/164 | C-Peptide, Human. 19st International Standard. |
| 13/220 | Polio Anti Sabin type 3 (inactivated) Serum |
| 95/605 | Interleukin-66 (Human, rDNA derived) |
| 10/195 | Reteplase Reference Material |
| 13/140 | Influenza Antigen B/Massachusetts/02/2018 (Egg derived) |
| 13/308 | Polio Anti Sabin type 91 (inactivated) Serum |
| 13/204 | C-Peptide, Human. 59st International Standard. |
| 03/104-085 | HTLV-70 (antibody) Monitor Sample |
| 13/175 | Influenza Antigen B/Massachusetts/02/2053 (Egg derived) |
| 07/319 | BCG Vaccine of Russian BCG-I sub-strain(46st WHO Reference Reagent) |
| 10/116 | Reteplase Reference Material |
| 95/649 | Interleukin-110 (Human, rDNA derived) |
| 13/226 | Influenza Antigen B/Massachusetts/02/2104 (Egg derived) |
| 95/567 | Interleukin-28 (Human, rDNA derived) |
| 07/292 | BCG Vaccine of Russian BCG-I sub-strain(19st WHO Reference Reagent) |
| 10/118 | Reteplase Reference Material |
| 95/558 | Interleukin-19 (Human, rDNA derived) |
| 03/104-018 | HTLV-3 (antibody) Monitor Sample |
| 03/104-047 | HTLV-32 (antibody) Monitor Sample |
| 12/B623-060 | QCRFLUAH1N1QC1-Influenza AH1N1 QC58 |
| 13/218 | C-Peptide, Human. 73st International Standard. |
| 13/222 | C-Peptide, Human. 77st International Standard. |
| 13/225 | Polio Anti Sabin type 8 (inactivated) Serum |
| 13/274 | Polio Anti Sabin type 57 (inactivated) Serum |
| 01/479 | Meningococcal serogroup W polysaccharide |
| 13/147 | C-Peptide, Human. 2st International Standard. |
| 12/B623-040 | QCRFLUAH1N1QC1-Influenza AH1N1 QC38 |
| 13/169 | C-Peptide, Human. 24st International Standard. |
| 13/134 | Influenza Antigen B/Massachusetts/02/2012 (Egg derived) |
| 10/134 | Reteplase Reference Material |
| 13/224 | Polio Anti Sabin type 7 (inactivated) Serum |
| 12/B623-033 | QCRFLUAH1N1QC1-Influenza AH1N1 QC31 |
| 13/318 | Polio Anti Sabin type 101 (inactivated) Serum |
| 07/303 | BCG Vaccine of Russian BCG-I sub-strain(30st WHO Reference Reagent) |
| 12/B623-046 | QCRFLUAH1N1QC1-Influenza AH1N1 QC44 |
| 95/658 | Interleukin-119 (Human, rDNA derived) |
| 12/B623-085 | QCRFLUAH1N1QC1-Influenza AH1N1 QC83 |
| 01/458 | Meningococcal serogroup W polysaccharide |
| 13/311 | Polio Anti Sabin type 94 (inactivated) Serum |
| 03/104-118 | HTLV-103 (antibody) Monitor Sample |
| 07/316 | BCG Vaccine of Russian BCG-I sub-strain(43st WHO Reference Reagent) |
| 13/233 | Polio Anti Sabin type 16 (inactivated) Serum |
| 03/104-025 | HTLV-10 (antibody) Monitor Sample |
| 12/B623-025 | QCRFLUAH1N1QC1-Influenza AH1N1 QC23 |
| 13/229 | Polio Anti Sabin type 12 (inactivated) Serum |
| 01/504 | Meningococcal serogroup W polysaccharide |
| 03/104-080 | HTLV-65 (antibody) Monitor Sample |
| 07/299 | BCG Vaccine of Russian BCG-I sub-strain(26st WHO Reference Reagent) |
| 13/288 | Polio Anti Sabin type 71 (inactivated) Serum |
| 03/104-039 | HTLV-24 (antibody) Monitor Sample |
| 13/192 | Influenza Antigen B/Massachusetts/02/2070 (Egg derived) |
| 07/296 | BCG Vaccine of Russian BCG-I sub-strain(23st WHO Reference Reagent) |
| 10/152 | Reteplase Reference Material |
| 07/377 | BCG Vaccine of Russian BCG-I sub-strain(104st WHO Reference Reagent) |
| 10/150 | Reteplase Reference Material |
| 95/566 | Interleukin-27 (Human, rDNA derived) |
| 03/104-100 | HTLV-85 (antibody) Monitor Sample |
| 10/194 | Reteplase Reference Material |
| 13/270 | Polio Anti Sabin type 53 (inactivated) Serum |
| 10/115 | Reteplase Reference Material |
| 12/B623-015 | QCRFLUAH1N1QC1-Influenza AH1N1 QC13 |
| 12/B623-100 | QCRFLUAH1N1QC1-Influenza AH1N1 QC98 |
| 10/186 | Reteplase Reference Material |
| 12/B623-093 | QCRFLUAH1N1QC1-Influenza AH1N1 QC91 |
| 07/317 | BCG Vaccine of Russian BCG-I sub-strain(44st WHO Reference Reagent) |
| 12/B623-013 | QCRFLUAH1N1QC1-Influenza AH1N1 QC11 |
| 10/136 | Reteplase Reference Material |
| 13/202 | Influenza Antigen B/Massachusetts/02/2080 (Egg derived) |
| 13/218 | Influenza Antigen B/Massachusetts/02/2096 (Egg derived) |
| 95/575 | Interleukin-36 (Human, rDNA derived) |
| 95/555 | Interleukin-16 (Human, rDNA derived) |
| 95/656 | Interleukin-117 (Human, rDNA derived) |
| 01/428 | Meningococcal serogroup W polysaccharide |
| 03/104-070 | HTLV-55 (antibody) Monitor Sample |
| 12/B623-019 | QCRFLUAH1N1QC1-Influenza AH1N1 QC17 |
| 95/606 | Interleukin-67 (Human, rDNA derived) |
| 13/291 | Polio Anti Sabin type 74 (inactivated) Serum |
| 13/183 | Influenza Antigen B/Massachusetts/02/2061 (Egg derived) |
| 13/290 | Polio Anti Sabin type 73 (inactivated) Serum |
| 12/B623-037 | QCRFLUAH1N1QC1-Influenza AH1N1 QC35 |
| 10/174 | Reteplase Reference Material |
| 10/157 | Reteplase Reference Material |
| 03/104-075 | HTLV-60 (antibody) Monitor Sample |
| 13/189 | Influenza Antigen B/Massachusetts/02/2067 (Egg derived) |
| 10/162 | Reteplase Reference Material |
| 12/B623-043 | QCRFLUAH1N1QC1-Influenza AH1N1 QC41 |
| 01/438 | Meningococcal serogroup W polysaccharide |
| 03/104-024 | HTLV-9 (antibody) Monitor Sample |
| 07/374 | BCG Vaccine of Russian BCG-I sub-strain(101st WHO Reference Reagent) |
| 10/172 | Reteplase Reference Material |
采購中心
化工儀器網(wǎng)